Company: KVACU
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001213900-25-021314
Chunk: 1175

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 10
Chunk 1175
---
 by the SparkLabs
Group, contributing to strategic planning, research, due diligence analyses, and deal structuring.

Prior to his current engagements,
Mr. Chu held executive positions at Zheng He Capital, a Hong Kong-based private equity firm, where he led investments in notable companies
such as Ping An Good Doctor and Lufax. Before his venture into finance, he successfully managed his family business, Lawman Group International,
and served as the Owner and President of Lawman Sportswear Inc., where he repositioned the Lawman brand in China and launched the Petrol
denim collection in the U.S. Presently, he holds the position of Vice President at Lawman International Limited, overseeing property management.

Mr. Chu started his career
at Booz-Allen & Hamilton, later holding positions at Merrill Lynch and Wit Soundview. He holds a B.A. in East Asian Studies from Harvard
University.

We believe Mr. Chu is well-qualified
to serve as a member of our board of directors given his experience, industry expertise, and network.

Professor YU, Albert
Cheung-Hoi, Ph.D., J.P.

Prof. Yu, one of our independent
directors since October 2021, has over 30 years of academic, industrial and entrepreneurial experience in biotech. Prof. Yu has been a
professor at Peking University since December 2001, where he researches glia and neuro-diseases. He has also served as founder, chairman
and Chief Scientific Officer of pioneering molecular diagnostic company Hai Kang Life Corporation Ltd since May 1999.

Concurrently, Prof. Yu serves
roles in 22 companies and organizations, including RNA interference (RNAi) therapeutics biopharmaceutical company Sirnaomics Ltd (independent
non-executive director since July 2021), venture capital fund CR-CP Life Science Fund Management Limited (independent director since May
2021), international biotech convention organizer BIOHK Limited (director since February 2019), the Biotech Advisory panel of the Stock
Exchange of Hong Kong Limited (HKEX) (panel member since April 2018), the Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance
(GBABA) (director, founder and chairman since December 2017), the Glia and Neuro-diseases Committee of the Beijing Society for Neuroscience
(BJSN) (director since December 2017), nonprofit international scientific conferences organizer, Gordon Research Conferences (member of